2017

1. Diez-Domingo J, Sanchez-Alonso V, Villanueva R-J, Acedo L, Morano J-A, Villanueva-Oller J. Random Network Models to Predict the Long-Term Impact of HPV Vaccination on Genital Warts. Viruses-Basel. 2017;9(10).

2. Iro MA, Snape MD, Voysey M, Jawad S, Finn A, Heath PT, et al. Persistence of bactericidal antibodies following, booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial (vol 35, pg 395, 2017). Vaccine. 2017;35(24):3279-.

3. Iro MA, Snape MD, Voysey M, Jawad S, Finn A, Heath PT, et al. Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial. Vaccine. 2017;35(2):395-402.

4. Munoz-Quiles C, Lopez-Lacort M, Javier Ampudia-Blasco F, Diez-Domingo J. Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009-2014. Human Vaccines & Immunotherapeutics. 2017;13(11):2606-11.

5. Navarro-Illana E, Lopez-Lacort M, Navarro-Illana P, Jose Vilata J, Diez-Domingo J. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain. Vaccine. 2017;35(25):3342-6.

6. Navarro-Illana P, Navarro-Illana E, Vila-Candel R, Diez-Domingo J. Drivers for human papillomavirus vaccination in Valencia (Spain). Gaceta sanitaria. 2017.

7. Orrico-Sanchez A, Lopez-Lacort M, Perez-Vilar S, Diez-Domingo J. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain. Bmc Infectious Diseases. 2017;17.

8. Perez-Breva L, Abad-Torreblanca R, Angel Martinez-Beneito M, Puig-Barbera J, Aleman-Sanchez S, Morant-Talamante N, et al. Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccination. Vaccine. 2017;35(22):2949-54.

9. Puig-Barbera J, Guglieri-Lopez B, Tortajada-Girbes M, Xavier Lopez-Labrador F, Carballido-Fernandez M, Mollar-Maseres J, et al. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season. Vaccine. 2017;35(52):7331-8.

10. Sadarangani M, Sell T, Iro MA, Snape MD, Voysey M, Finn A, et al. Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules. Canadian Medical Association Journal. 2017;189(41):E1276-E85.

11. Youngster I, Avorn J, Belleudi V, Cantarutti A, Diez-Domingo J, Kirchmayer U, et al. Antibiotic Use in Children - A Cross-National Analysis of 6 Countries. Journal of Pediatrics. 2017;182:239-44.